Natural Product: NPC489822

Natural Product IDNPC489822
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
QDSFCWAUKOHAOZ-HVYTWZIXSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0001995] Cyclic peptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QDSFCWAUKOHAOZ-HVYTWZIXSA-N
Standard InCHI InChI=1S/C35H52N8O9S/c1-6-19(2)28-35(51)43-15-10-13-26(43)34(50)41-24(17-22-11-8-7-9-12-22)33(49)40-25(18-27(36)44)32(48)38-20(3)29(45)39-23(14-16-53(5)52)31(47)37-21(4)30(46)42-28/h7-9,11-12,19-21,23-26,28H,6,10,13-18H2,1-5H3,(H2,36,44)(H,37,47)(H,38,48)(H,39,45)(H,40,49)(H,41,50)(H,42,46)/t19-,20-,21-,23-,24-,25-,26-,28-,53?/m0/s1
SMILES CC[C@H](C)[C@H]1C(=O)N2CCC[C@H]2C(=N[C@@H](Cc2ccccc2)C(=N[C@@H](CC(=N)O)C(=N[C@@H](C)C(=N[C@@H](CCS(=O)C)C(=N[C@@H](C)C(=N1)O)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   760.36 Volume:   744.841
?
Van der Waals volume.
Dense:   1.021 LogP:   -0.749
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.349
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.345
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   33.0
TPSA:   282.99
?
Topological Polar Surface Area.
H-Bond Acceptor:   17.0
H-Bond Donor:   8.0 Rings:   3.0
Heavy Atoms:   18.0

MedChem Properties

QED Drug-Likeness Score:   0.103 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   6.599 Fsp3:   0.6
MCE-18:   94.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.343 Fluc inhibitor:   0.168
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.04
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.452
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.156 Promiscuous compounds:   0.022

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.776 MDCK Permeability:   -5.304
Pgp-inhibitor:   0.584 Pgp-substrate:   1.0
PAMPA:   0.972
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.933
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.956
Plasma Protein Binding (PPB):   63.021% Volume Distribution (VD):   -0.254
Fu: 33.409%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.959
OATP1B3 inhibitor:   0.641 BCRP inhibitor:   0.095
BSEP inhibitor:   0.755

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.051 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.231 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.008
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.759 Half-life (T1/2):  2.371

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.087 Rat Oral Acute Toxicity:  0.959
Maximum Recommended Daily Dose:  0.389 Skin Sensitization:  1.0
Carcinogencity:  0.653 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.805
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.999
Hematotoxicity:  0.756 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.0
BCF:   0.242
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.913
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.515
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.573
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27991 Stylissa flabelliformis Species Axinellidae Eukaryota n.a. Maldive Islands 1995 PMID[18327911]
NPO27991 Stylissa flabelliformis Species Axinellidae Eukaryota n.a. n.a. n.a. PMID[29893558]
NPO27991 Stylissa flabelliformis Species Axinellidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO27991 Stylissa flabelliformis Species Axinellidae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2890 Protein complex Sodium/potassium-transporting ATPase Homo sapiens IC50 > 100000.0 nM PMID[29893558]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 12000.0 nM PMID[29893558]
NPT111 Cell line K562 Homo sapiens IC50 = 11000.0 nM PMID[29893558]
NPT393 Cell line HCT-116 Homo sapiens IC50 = 12000.0 nM PMID[29893558]
NPT81 Cell line A549 Homo sapiens IC50 = 15000.0 nM PMID[29893558]
NPT1086 Cell line SK-HEP1 Homo sapiens IC50 = 13000.0 nM PMID[29893558]
NPT2548 Cell line SNU-638 Homo sapiens IC50 = 12000.0 nM PMID[29893558]
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC > 128000.0 nM PMID[29893558]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium MIC > 128000.0 nM PMID[29893558]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC > 128000.0 nM PMID[29893558]
NPT20 Organism Candida albicans Candida albicans MIC > 128000.0 nM PMID[29893558]
NPT329 Organism Trichophyton rubrum Trichophyton rubrum MIC > 128000.0 nM PMID[29893558]
NPT330 Organism Trichophyton mentagrophytes Trichophyton mentagrophytes MIC > 128000.0 nM PMID[29893558]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 128000.0 nM PMID[29893558]
NPT766 Organism Proteus vulgaris Proteus vulgaris MIC > 128000.0 nM PMID[29893558]
NPT19 Organism Escherichia coli Escherichia coli MIC > 128000.0 nM PMID[29893558]
NPT87 Organism Aspergillus fumigatus Aspergillus fumigatus MIC > 128000.0 nM PMID[29893558]
NPT2 Others Unspecified n.a. IC50 > 100000.0 nM PMID[29893558]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC489822 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8077 Intermediate Similarity NPC322878
0.6941 Remote Similarity NPC241794
0.6905 Remote Similarity NPC479070
0.631 Remote Similarity NPC479072
0.6026 Remote Similarity NPC200589
0.6024 Remote Similarity NPC489591
0.602 Remote Similarity NPC489823
0.5952 Remote Similarity NPC489557
0.5952 Remote Similarity NPC479068
0.5934 Remote Similarity NPC489827
0.5833 Remote Similarity NPC328649
0.5814 Remote Similarity NPC489824
0.5765 Remote Similarity NPC287401
0.5682 Remote Similarity NPC489556
0.5625 Remote Similarity NPC489828
0.5591 Remote Similarity NPC479069
0.5581 Remote Similarity NPC248283
0.5581 Remote Similarity NPC202198
0.5568 Remote Similarity NPC489592
0.5556 Remote Similarity NPC5194
0.5506 Remote Similarity NPC6975
0.5476 Remote Similarity NPC242482
0.5465 Remote Similarity NPC255447
0.5412 Remote Similarity NPC489593
0.5412 Remote Similarity NPC224315
0.5385 Remote Similarity NPC56685
0.5376 Remote Similarity NPC489825
0.5294 Remote Similarity NPC110602
0.5294 Remote Similarity NPC479071
0.5227 Remote Similarity NPC200964
0.5213 Remote Similarity NPC261934
0.5213 Remote Similarity NPC489826
0.5169 Remote Similarity NPC485094
0.5169 Remote Similarity NPC489829
0.5161 Remote Similarity NPC479074
0.5155 Remote Similarity NPC302597
0.5106 Remote Similarity NPC136797
0.5098 Remote Similarity NPC31385
0.5096 Remote Similarity NPC296968
0.5093 Remote Similarity NPC326349
0.5093 Remote Similarity NPC323336
0.5053 Remote Similarity NPC101679

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC489822 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data